Copyright Reports & Markets. All rights reserved.

Global General Influenza Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global General Influenza Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 RIDT
    • 1.2.3 Viral Culture
    • 1.2.4 DFA
    • 1.2.5 Serological Assays
  • 1.3 Market by Application
    • 1.3.1 Global General Influenza Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Clinical Laboratories
    • 1.3.4 Other End-User
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global General Influenza Diagnostics Market Perspective (2015-2026)
  • 2.2 Global General Influenza Diagnostics Growth Trends by Regions
    • 2.2.1 General Influenza Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 General Influenza Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 General Influenza Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top General Influenza Diagnostics Players by Market Size
    • 3.1.1 Global Top General Influenza Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global General Influenza Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global General Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by General Influenza Diagnostics Revenue
  • 3.4 Global General Influenza Diagnostics Market Concentration Ratio
    • 3.4.1 Global General Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by General Influenza Diagnostics Revenue in 2019
  • 3.5 Key Players General Influenza Diagnostics Area Served
  • 3.6 Key Players General Influenza Diagnostics Product Solution and Service
  • 3.7 Date of Enter into General Influenza Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 General Influenza Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global General Influenza Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global General Influenza Diagnostics Forecasted Market Size by Type (2021-2026)

5 General Influenza Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global General Influenza Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global General Influenza Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America General Influenza Diagnostics Market Size (2015-2026)
  • 6.2 North America General Influenza Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America General Influenza Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America General Influenza Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe General Influenza Diagnostics Market Size (2015-2026)
  • 7.2 Europe General Influenza Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe General Influenza Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe General Influenza Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China General Influenza Diagnostics Market Size (2015-2026)
  • 8.2 China General Influenza Diagnostics Market Size by Type (2015-2020)
  • 8.3 China General Influenza Diagnostics Market Size by Application (2015-2020)
  • 8.4 China General Influenza Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan General Influenza Diagnostics Market Size (2015-2026)
  • 9.2 Japan General Influenza Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan General Influenza Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan General Influenza Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia General Influenza Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia General Influenza Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia General Influenza Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia General Influenza Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 F. Hoffmann-La Roche
    • 11.1.1 F. Hoffmann-La Roche Company Details
    • 11.1.2 F. Hoffmann-La Roche Business Overview
    • 11.1.3 F. Hoffmann-La Roche General Influenza Diagnostics Introduction
    • 11.1.4 F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2015-2020))
    • 11.1.5 F. Hoffmann-La Roche Recent Development
  • 11.2 Quidel Corporation
    • 11.2.1 Quidel Corporation Company Details
    • 11.2.2 Quidel Corporation Business Overview
    • 11.2.3 Quidel Corporation General Influenza Diagnostics Introduction
    • 11.2.4 Quidel Corporation Revenue in General Influenza Diagnostics Business (2015-2020)
    • 11.2.5 Quidel Corporation Recent Development
  • 11.3 Thermo Fisher Scientific
    • 11.3.1 Thermo Fisher Scientific Company Details
    • 11.3.2 Thermo Fisher Scientific Business Overview
    • 11.3.3 Thermo Fisher Scientific General Influenza Diagnostics Introduction
    • 11.3.4 Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2015-2020)
    • 11.3.5 Thermo Fisher Scientific Recent Development
  • 11.4 Abbott Laboratories
    • 11.4.1 Abbott Laboratories Company Details
    • 11.4.2 Abbott Laboratories Business Overview
    • 11.4.3 Abbott Laboratories General Influenza Diagnostics Introduction
    • 11.4.4 Abbott Laboratories Revenue in General Influenza Diagnostics Business (2015-2020)
    • 11.4.5 Abbott Laboratories Recent Development
  • 11.5 Becton, Dickinson, and Company
    • 11.5.1 Becton, Dickinson, and Company Company Details
    • 11.5.2 Becton, Dickinson, and Company Business Overview
    • 11.5.3 Becton, Dickinson, and Company General Influenza Diagnostics Introduction
    • 11.5.4 Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2015-2020)
    • 11.5.5 Becton, Dickinson, and Company Recent Development
  • 11.6 DiaSorin
    • 11.6.1 DiaSorin Company Details
    • 11.6.2 DiaSorin Business Overview
    • 11.6.3 DiaSorin General Influenza Diagnostics Introduction
    • 11.6.4 DiaSorin Revenue in General Influenza Diagnostics Business (2015-2020)
    • 11.6.5 DiaSorin Recent Development
  • 11.7 bioMérieux
    • 11.7.1 bioMérieux Company Details
    • 11.7.2 bioMérieux Business Overview
    • 11.7.3 bioMérieux General Influenza Diagnostics Introduction
    • 11.7.4 bioMérieux Revenue in General Influenza Diagnostics Business (2015-2020)
    • 11.7.5 bioMérieux Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    General Influenza Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global General Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    RIDT
    Viral Culture
    DFA
    Serological Assays

    Market segment by Application, split into
    Hospitals
    Clinical Laboratories
    Other End-User

    Based on regional and country-level analysis, the General Influenza Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global General Influenza Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    F. Hoffmann-La Roche
    Quidel Corporation
    Thermo Fisher Scientific
    Abbott Laboratories
    Becton, Dickinson, and Company
    DiaSorin
    bioMérieux
    Buy now